Clinical Trials Logo

Roux-en-y Anastomosis Site clinical trials

View clinical trials related to Roux-en-y Anastomosis Site.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05655975 Not yet recruiting - Obesity, Morbid Clinical Trials

Regain Rate According to gj Anastomosis Size in Gastric Bypass

Start date: December 15, 2022
Phase: N/A
Study type: Interventional

Obesity has become an important medical and social problem in western countries today. Roux-en-Y gastric bypass (LRYGB) is the most commonly performed surgery for the treatment of morbid obesity in the United States. Recently, there has been a steady increase in the number of surgeons performing bariatric surgery. In 2008, approximately 344,000 bariatric procedures were performed worldwide, of which 220,000 were performed in the United States and Canada. Most of these surgeries were laparoscopic gastric bypass procedures. There are many technical variations in the performance of the Roux-en-Y gastric bypass, especially when the approach is laparoscopic. Three techniques are commonly used when creating a gastrojejunostomy (GJ): hand-sewn, linear-staple, and circular-staple approaches. The effect of larger-caliber gastrojejunostomy on long-term weight loss is worrisome. Numerous recent reports describe the relationship between gastrojejunostomy enlargement and weight gain after gastric bypass, suggesting that this is a potentially valid concern. In this study, we aim to determine the effect of this potential GJ enlargement on weight loss.